Biofrontera Inc. (BFRI)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceuticals	37.32M	34.07M	28.67M	24.10M	18.85M
Pharmaceuticals Growth	9.54%	18.82%	18.98%	27.86%	-28.01%
Total	37.32M	34.07M	28.67M	24.10M	18.85M
Total Growth	9.54%	18.82%	18.98%	27.86%	-28.01%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	37.32M	34.07M	28.67M	24.10M	18.85M
United States Growth	9.54%	18.82%	18.98%	27.86%	-28.01%
Total	37.32M	34.07M	28.67M	24.10M	18.85M
Total Growth	9.54%	18.82%	18.98%	27.86%	-28.01%

Source: S&P Global Market Intelligence.